ProTrials Research Celebrates 15 Years
In 1996, Jodi Andrews and Inger Arum had a vision: to build a clinical research organization (CRO) that could deliver personalized service and high quality data within an environment that achieves a work/life balance and eco-sensitivity. Both experienced clinical researchers, they knew the key to achieving their vision was to collaborate with other highly trained professionals. And so, from its inception, ProTrials Research, Inc. has offered a top-notch team of research specialists, each with one of the industry’s highest average lengths of experience. Just as importantly, the ProTrials team collectively works toward mitigating their sponsors’ risk of potentially losing millions of dollars by producing the best, reliable data on time and on budget.
From the start, ProTrials has kept a vigilant eye on its core values – excellence, collaboration, integrity, promise, community and balance. In the early years, as it worked hard to gain a reputation as a trusted partner for clinical research management, it landed a series of Phase 3 immunology studies. One was a high profile, international study for a groundbreaking HIV vaccine, and its successful completion solidified ProTrials’ name as being synonymous with excellence.
Today, ProTrials offers a comprehensive suite of services and global support for Phase 1 – 4 clinical trials to the pharmaceutical, biotechnology and medical device markets within a broad range of therapeutic areas, including oncology, cardiology, ophthalmology, infectious diseases and neurosciences. ProTrials has successfully completed over 300 studies to date, ranging from small investigational trials to large, multi-site studies involving thousands of patients. Its more than 85 employees average 15 years of industry experience; the company’s over 90 percent employment retention rate, one of the highest for any CRO, gives sponsors the assurance that teams will remain in place for the duration of their studies.
Leave a comment |